| Synonyms: | |
| Status: | Approved (1981) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | C03DB01 |
| UNII: | 7DZO8EB0Z3 |
| InChI Key | XSDQTOBWRPYKKA-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C6H8ClN7O |
| Molecular Weight | 229.63 |
| AlogP | -1.08 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 5.0 |
| Number of Rotational Bond | 1.0 |
| Polar Surface Area | 156.79 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 15.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Oxidoreductase
|
- | - | - | 10000 | - | |
|
Enzyme
Protease
Serine protease
Serine protease PA clan
Serine protease S1A subfamily
|
- | 2400-11980 | - | 2433-7000 | 0-23 | |
|
Ion channel
Ligand-gated ion channel
Acid-sensing ion channel
|
- | 30200 | - | - | 22-65 | |
|
Ion channel
Ligand-gated ion channel
Epithelial sodium channel
|
- | 776 | - | - | 68 | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Nucleotide-like receptor (family A GPCR)
Adenosine receptor
|
- | - | - | 3280-12000 | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC09 family of sodium/hydrogen exchangers
|
- | 60000-66730 | - | - | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC22 family of organic cation and anion transporters
|
- | 57000 | - | - | 69 | |
|
Unclassified protein
|
- | 98000 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hypertension | 3 | D006973 | ClinicalTrials |
| Optic Neuritis | 2 | D009902 | ClinicalTrials |
| Demyelinating Diseases | 2 | D003711 | ClinicalTrials |
| Coronary Disease | 2 | D003327 | ClinicalTrials |
| Hyperparathyroidism, Primary | 2 | D049950 | ClinicalTrials |
| Multiple Sclerosis, Chronic Progressive | 2 | D020528 | ClinicalTrials |
| Migraine with Aura | 2 | D020325 | ClinicalTrials |
| Cystic Fibrosis | 1 | D003550 | ClinicalTrials |
| Attention Deficit Disorder with Hyperactivity | 0 | D001289 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 2609-46-3 |
| ChEBI | 2639 |
| ChEMBL | CHEMBL945 |
| DrugBank | DB00594 |
| DrugCentral | 158 |
| EPA CompTox | DTXSID9043853 |
| FDA SRS | 7DZO8EB0Z3 |
| Human Metabolome Database | HMDB0014732 |
| Guide to Pharmacology | 2421 |
| KEGG | C06821 |
| PDB | AMR |
| PharmGKB | PA448368 |
| PubChem | 16231 |
| SureChEMBL | SCHEMBL27562 |
| ZINC | ZINC000004340269 |